Sylvia Cheung
Directeur Financier/CFO chez OCULIS HOLDING AG
Fortune : 785 662 $ au 31/05/2024
Postes actifs de Sylvia Cheung
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCULIS HOLDING AG | Directeur Financier/CFO | 01/09/2020 | - |
| Public Communications Contact | 01/09/2020 | - |
Historique de carrière de Sylvia Cheung
Anciens postes connus de Sylvia Cheung
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2005 | 10/08/2020 |
| Directeur Financier/CFO | 01/04/2013 | 10/08/2020 | |
| Investor Relations Contact | 01/10/2005 | 10/08/2020 | |
| Secrétaire Général | 01/04/2013 | 04/03/2020 | |
| Treasurer | 01/04/2013 | 10/08/2020 | |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 01/01/2000 | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/1995 | 01/01/2000 |
Formation de Sylvia Cheung
| University of Massachusetts | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Pays-Bas | 2 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| OCULIS HOLDING AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Bourse
- Insiders
- Sylvia Cheung
- Expérience
